NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Baird Medical Investment Holdings Limited (BDMD) Stock Analysis

Baird Medical Investment Holdings Limited (BDMD) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

BDMD

$0.48

−$0.01 (−1.16%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare BDMD with… →

BDMD Key Statistics

As of Oct 21, 2026
Trading
Open
$0.46
Previous Close
$0.48
Day's Range
0.46–0.55
52-Week Range
0.40–3.70
Volume
31.30K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
−1.12
Valuation
Market Cap
$15.47M
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
3.44
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.63
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.55
Financials (FY)
Revenue (FY)
$22.54M−39.15%
Net Income (FY)
−$27.28M−319.04%
Profit marginThe share of revenue left as profit after all costs and taxes.
−65.12%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
32.11M
1-Year Return
−70.06%
Dividend and dates
Avg Volume
56.13K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, BDMD closed at $0.48, −70.06% over 1 year.

Baird Medical Investment Holdings Limited (BDMD) has a market capitalization of $15.47M.

In fiscal 2025, BDMD reported revenue of $22.54M.

BDMD Stock Return by Calendar Year

Baird Medical Investment Holdings Limited (BDMD) return since Dec 2021: what $10,000 became

1 year
$10,000 $2,994
−70.06%
3 years
$10,000 $447
−95.53%
Since Dec 2021
$10,000 $492
−95.08%

If you had invested $10,000 in Baird Medical Investment Holdings Limited (BDMD) at the close on December 16, 2021, the earliest close on record here, it would have been worth $492 at the close on October 21, 2026: −95.08% in total, −46.28% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−65.00%
2025−82.11%
2024−29.04%
2023+4.39%
2022+4.06%
2021 (partial year)+1.96%

As of October 21, 2026.

BDMD Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$22.54M−$27.28M−121.0%
2024$37.04M$12.45M33.6%
2023$31.46M$10.55M33.5%
2022$35.09M$12.57M35.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$22.54M$18.88M−$25.54M−$27.28M−121.0%
2024$37.04M$32.65M$15.32M$12.45M33.6%
2023$31.46M$27.23M$12.65M$10.55M33.5%
2022$35.09M$28.04M$15.01M$12.57M35.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

BDMD Valuation vs Medical Devices Median

Median of 145 stocks
MetricBDMDMedical Devices medianvs median
P/S ratio0.632.530.2x the median
Profit margin−65.12%−14.78%50.3 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 11 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Baird Medical Investment Holdings Limited (BDMD) carries a market capitalisation of $15.47M. It is classified in the Medical Devices industry, within the Healthcare sector. Headcount on file is 146.

The most recent close on file for BDMD is $0.48, dated October 21, 2026. That is −$0.01 (−1.16%) against the previous close. The 52-week range on file runs from $0.40 to $3.70. The latest close sits 19% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $22.54M. Against the prior fiscal year total of $37.04M, that is a change of −39.15%. The same year closed with a net loss of $27.28M. The reported profit margin is −65.12%. That is 50.3 percentage points below the Medical Devices median of −14.78%. Trailing earnings per share are −0.55.

Across the 4 fiscal years on file, revenue moves from $35.09M in 2022 to $22.54M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. On forward earnings the ratio is 3.44. Measured against sales, the shares trade at 0.63 times revenue. On price-to-sales that is 0.2 times the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

Over the trailing twelve months the total return is −70.06%. Across 3 years the annualized return works out at −64.52%. The reported beta is −1.12. Annualized volatility over the trailing 4 years is 329.88%.

Growth & Income

No dividend is on file for BDMD.

The strongest complete calendar year on file is 2023 at +4.39%; the weakest is 2025 at −82.11%. Of the 4 complete calendar years on file, 2 finished higher. 2026 is still running; the total return is −65.00% year to date.

Peer Comparison

Baird Medical Investment Holdings Limited (BDMD) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Baird Medical Investment Holdings Limited BDMD $15.47M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Baird Medical Investment Holdings Limited has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Baird Medical Investment Holdings Limited

Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; and long and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, and uterine fibroids, as well as soft tissue ablation. It sells its products through third-party distributors. It has a strategic cooperation agreement with Tianjin Yuanshan Medical Technology Co., Ltd. to focus on global development and commercialization of next-generation IRE technologies. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.

Visit website →